CTIBIOTECH Undisclosed

CTIBIOTECH — Revolutionizing cancer research with 3D bioprinted microtumors.

www.ctibiotech.com LinkedInBiotechnology, Healthcare, Cancer Research

Round summary

CTIBIOTECH has secured €1.3 million in funding, marking its first major investment round. This capital will fuel the development of their CTIONCOTEST™ project, which utilizes 3D bioprinted microtissues for cancer research. The funding comes from France 2030 and Bpifrance, supporting CTIBIOTECH's goal to revolutionize cancer research with innovative bio-printing technology.

Investors (1)

France 2030

CTIBIOTECH's other rounds

CTIBIOTECH

Funding Round · Apr 28, 2026

$3M

Loading investment round...